Category: Regulatory/FDA

CHC_general1

05/04/2018

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says

CHC_general2

03/26/2018

FDA Announces Mobile App to Help Consumers Get Drug Info

CHC_DTCadvertisement1

03/14/2018

FDA Ramps Up Drug Promotion Research Focus

CHC_FDA-Regulatory Images1

03/07/2018

CBER’s APLB Issues First Enforcement Letter Since 2015 for Misleading Efficacy Claims

CHC_FDA-Regulatory Images1

02/23/2018

First 2018 OPDP Enforcement Letter Targets Exhibit Booth for Opioid

CHC_general2

01/24/2018

OPDP Enforcement Letter Grand Total for 2017: Five

CHC_FDA-Regulatory Images1

01/15/2018

FDA Calls for Additional Comment on Revised Intended Use Language

CHC_offLabel

12/22/2017

FDA To Study Consumer, HCP Ability to Spot Deceptive Drug Ads

CHC_FDA-Regulatory Images1

12/15/2017

FDA Finalizes Guidance on Name Placement, Size and Prominence